MedPath

NEUPRO

NEUPRO

Approved
DIN Number

02403897

Drug Class

Human

Market Date

Dec 19, 2013

Company
HC

UCB Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02403897
AIG Number0154150001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BC09 ROTIGOTINE
Product Specifications
Dosage FormPatch
Route of AdministrationTransdermal
AHFS Classification28:36.20.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

ROTIGOTINEActive
Strength: 1 MG / 24 HOUR
Monograph: ROTIGOTINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.